Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ATG7 | O95352 | 19/20 | 0.51 |
| ▸ | ADORA3 | P0DMS8 | 1/20 | 0.48 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5087918 | 1.00 | ATG7 (0.51) | ATG7ADORA3ADORA2A | |
| SCHEMBL13669400 | 0.91 | ATG7 (0.50) | ATG7ADORA3ADORA2A | |
| SCHEMBL887667 | 0.85 | ATG7 (0.53) | ATG7 | |
| SCHEMBL1512938 | 0.83 | ATG7 (0.52) | ATG7 | |
| SCHEMBL532323 | 0.83 | ATG7 (0.52) | ATG7 | |
| SCHEMBL6579936 | 0.83 | ATG7 (0.52) | ATG7 | |
| SCHEMBL12762314 | 0.83 | ATG7 (0.54) | ATG7 | |
| SCHEMBL14038325 | 0.83 | ATG7 (0.57) | ATG7 | |
| SCHEMBL20141774 | 0.82 | ATG7 (0.71) | ATG7 | |
| SCHEMBL20142486 | 0.82 | ATG7 (0.71) | ATG7 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20060009628-A1 | MODIFIED OLIGONUCLEOTIDES FOR MISMATCH DISCRIMINATION | ELITECHGROUP, INC. | 2006-01-12 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20060009628-A1 | MODIFIED OLIGONUCLEOTIDES FOR MISMATCH DISCRIMINATION | MSH2, RNGTT, DCLRE1B | ATG7 4773/4885ADORA3 374/4885ADORA2A 779/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.